- Home
- HODO vs RNAZ Comparison
HODO vs RNAZ Comparison
Compare HODO & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.87
HOLD
Current Price
$4.79
Company Overview
Basic Information| Metric | HODO | RNAZ |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 8.3M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HODO | RNAZ |
|---|---|---|
| Price | $0.87 | $4.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 26.0K |
| Earning Date | N/A | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.48 | $3.82 |
| 52 Week High | $2.52 | $20.99 |
Technical Indicators
Market Signals| Indicator | HODO | RNAZ |
|---|---|---|
| Relative Strength Index (RSI) | 20.09 | 34.33 |
| Support Level | $0.85 | $3.95 |
| Resistance Level | $1.39 | $6.15 |
| Average True Range (ATR) | 0.30 | 1.06 |
| MACD | -0.02 | -0.46 |
| Stochastic Oscillator | 29.29 | 3.71 |
Price Performance
Historical Comparison HODO
RNAZ
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.